MedTrace Logo

Routine Calcium for Preventing Hypocalcemia

NCT03484416 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2018-03-30

No results posted yet for this study

Summary

The present study investigated the effect of routine calcium and vitamin D supplementation and tried to find the predictors for postoperative hypocalcemia in patients with thyroid cancer.

Conditions

  • Thyroid Neoplasm

Interventions

DRUG

Calcium Carbonate 1500 Mg with Vitamin D

Patients in the routine calcium group received oral supplements of 1,500 mg/day elemental calcium and 1,000 IU/day cholecalciferol (Dicamax 1000) for 2 weeks, whereas control group did not

Sponsors & Collaborators

  • Ewha Womans University Mokdong Hospital

    lead OTHER

Principal Investigators

  • Hyungju Kwon, MD · Ewah Womans University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2017-05-30
Completion
2017-05-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03484416 on ClinicalTrials.gov